Tag: biotech sector

Most of you know our Big View product, since I often talk about our risk gauges. In fact, I can report to you that our risk gauges...

Biotechnology has traded basically sideways since the start of 2023. In the face of higher rates, stronger dollar, inflation, FDA approvals and busts, and an...

The market has turned for the worst in recent weeks and continues to fall in a bear market fashion.  Most of our portfolio strategies are...

Wednesday, the small cap Russell 2000 ETF (IWM) made a divergence in price and our momentum indicator Real Motion (RM). In the above chart we...

The past week was a chop fest in the major stock market indices with large intraday price swings. While the 3 major indices closed roughly...

The past four trading days have held roughly the same price areas within the major indices. Specifically, the S&P 500 (SPY) and the Nasdaq 100...

For roughly three months the biotechnology ETF (IBB) has been trending lower.  Though it’s made multiple attempts to clear the 50-Day moving average (DMA), it...

In the past couple of weeks, the stock market has shown to have higher volatility paired with scattered daily price action. With the recent discovery...

With all but one member of the Economic Modern Family of stock market ETFs in a bullish phase should we be worried, or does...

Those of you who are new to the Daily, you probably noticed the references to the Economic Modern Family. Mish developed one index and five...